ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 87 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $7,000 | -98.8% | 2,200 | -96.6% | 0.00% | -100.0% |
| Q1 2017 | $592,000 | +19.4% | 64,307 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $496,000 | -32.5% | 64,307 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $735,000 | -7.2% | 64,307 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $792,000 | +21.8% | 64,307 | 0.0% | 0.01% | +16.7% |
| Q1 2016 | $650,000 | -55.1% | 64,307 | 0.0% | 0.01% | -57.1% |
| Q4 2015 | $1,449,000 | +32.2% | 64,307 | -2.7% | 0.01% | +27.3% |
| Q3 2015 | $1,096,000 | -26.3% | 66,070 | 0.0% | 0.01% | -38.9% |
| Q2 2015 | $1,487,000 | +2.4% | 66,070 | +17.4% | 0.02% | +12.5% |
| Q1 2015 | $1,452,000 | +18.4% | 56,300 | 0.0% | 0.02% | +14.3% |
| Q4 2014 | $1,226,000 | – | 56,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 825,647 | $19,238,000 | 3.04% |
| SECTORAL ASSET MANAGEMENT INC | 1,392,485 | $32,445,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,000 | $1,748,000 | 0.43% |
| Eventide Asset Management | 52,800 | $1,230,000 | 0.17% |
| Alyeska Investment Group, L.P. | 250,434 | $5,835,000 | 0.13% |
| Convergence Investment Partners, LLC | 28,715 | $669,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 253,348 | $5,903,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 66,800 | $1,557,000 | 0.04% |
| Visium Asset Management, LP | 75,001 | $1,748,000 | 0.03% |
| Hodges Capital Management Inc. | 15,000 | $349,000 | 0.02% |